Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Acquired Dysfibrinogenemia Krakow III after Everolimus Therapy

Alona A. Merkulova, MA, Steven C. Mitchell, MA, Sergei Merkulov, PhD, Alisa S. Wolberg, PhD, Neerman-Arbez Marguerite, PhD, Alvin H. Schmaier, MD

Blood (2019) 134 (Supplement_1): 4934.

https://doi.org/10.1182/blood-2019-131319

Published: 2019

Journal Articles

A Pilot Study of Exjade (Deferasirox) As Monotherapy in Higher Risk MDS or Acute Myeloid Leukemia

James K. Mangan, MD PhD, Imran Ajmal, MBBS, Noelle V. Frey, MD, Elizabeth O. Hexner, MD, Alison W. Loren, MD MSCE, Martin Carroll, MD, Selina M. Luger, MD FRCPC

Blood (2019) 134 (Supplement_1): 5155.

https://doi.org/10.1182/blood-2019-131668

Published: 2019

Journal Articles

Von Willebrand Disease and Gastrointestinal Bleeding: A National Inpatient Sample (NIS) Study

Anastasia Tsagianni, MD, Margaret V. Ragni, MD MPH, Diane M. Comer, BS, Jonathan G. Yabes, PhD

Blood (2018) 132 (Supplement 1): 1179.

https://doi.org/10.1182/blood-2018-99-111731

Published: 2018

Journal Articles

Efficacy and Safety of Defibrotide in Pediatric Patients with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Stem Cell Transplantation (HSCT): Final Results from the Expanded-Access Program

Nancy A. Kernan, MD, Angela R. Smith, MD MS, Brandon Triplett, MD, Leslie Lehmann, MD, Robert J. Ryan, Wei Liang, Robin L. Hume, MS, William Martin Tappe, MD, Stephan A Grupp, MD PhD

Blood (2017) 130 (Supplement 1): 1948.

https://doi.org/10.1182/blood.V130.Suppl_1.1948.1948

Published: 2017

Journal Articles

Acquired Factor X Deficiency in Systemic Light Chain Amyloidosis: Factor X Recovery after Bleeding Complications, Splenectomy, Chemotherapy and Remission

Rosa Toenges, MD, Juliane Steinmann, MD, Annelie Siegemund, MD, Hubert Serve, Wolfgang A. Miesbach, MD PhD

Blood (2017) 130 (Supplement 1): 4892.

https://doi.org/10.1182/blood.V130.Suppl_1.4892.4892

Published: 2017

Journal Articles

Localization, Management, Resource Consumption and Outcome of Major Gastrointestinal Bleeding in Patients with Direct Oral Anticoagulants, Vka and Antiplatelet Therapy

Sven Pannach, MD, Julia Goetze, Luise Tittl, B.Sc., Thomas Schreier, Sandra Marten, MD, Jochen Hampe, MD, Jan Beyer-Westendorf, MD

Blood (2016) 128 (22): 141.

https://doi.org/10.1182/blood.V128.22.141.141

Published: 2016

Journal Articles

A Phase Ib/II Study of Ibrutinib in Combination with Obinutuzumab-Gazyva As First-Line Treatment for Patients with Chronic Lymphocytic Leukemia > 65 Years Old or with Coexisting Conditions

Carlos I. Amaya-Chanaga, MD, Michael Y. Choi, MD, Natalie Nguyen, B.Sc, Elizabeth DeVore, B.Sc, Colin MacCarthy, B.Sc, Jacqueline Hilger-Rolfe, PhD, M.S., Thomas J. Kipps, MD, PhD, Januario E. Castro, MD

Blood (2016) 128 (22): 2048.

https://doi.org/10.1182/blood.V128.22.2048.2048

Published: 2016

Journal Articles

Final Results of Phase 1 MMRC Trial of Selinexor, Carfilzomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma (RRMM)

Andrzej Jakubowiak, MDPhD, Jagoda Jasielec, MD, Cara A. Rosenbaum, MD, Craig E. Cole, MD, Ajai Chari, MD, Jennifer Nam, Erica Severson, Leonor A Stephens, PhD, Kathryn McDonnell, Shaun Rosebeck, PhD, Todd Zimmerman, MD, Theodore Karrison, PhD, Jeffrey Zonder, MD

Blood (2016) 128 (22): 973.

https://doi.org/10.1182/blood.V128.22.973.973

Published: 2016

Journal Articles

Bleeding and Liver Transplant Outcomes in Hemophilia

Kathan Dilipbhai Mehta, MBBS, MPH, Margaret V. Ragni, MD MPH

Blood (2015) 126 (23): 760.

https://doi.org/10.1182/blood.V126.23.760.760

Published: 2015

Journal Articles

FEIBA™ for Reversal of Direct Oral Anticoagulant Associated Major Bleeding

Joseph Shaw, B.Sc, Gregoire Le Gal, MDPhD, Melanie Tokessy, Nancy Cober, Elianna Saidenberg, MD, Marc Carrier, MDMSc, Lana Castellucci, MDMSc

Blood (2014) 124 (21): 1540.

https://doi.org/10.1182/blood.V124.21.1540.1540

Published: 2014

Journal Articles

A Phase 1/2, Open-Label, Dose-Escalation, Multi-Center Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered NS-018 in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (postPV MF), or Post-Essential Thrombocythemia Myelofibrosis (postET MF)

Srdan Verstovsek, MD PhD, Moshe Talpaz, MD, Ellen K. Ritchie, MD, Martha Wadleigh, MD, Olatoyosi Odenike, MD, Catriona Jamieson, MD PhD, Brady L Stein, MD, Uno Tomonori, PhD, Ruben Mesa, MD

Blood (2014) 124 (21): 1839.

https://doi.org/10.1182/blood.V124.21.1839.1839

Published: 2014

Journal Articles

Bosutinib As Therapy For Chronic Phase Chronic Myeloid Leukemia Following Failure With Imatinib Plus Dasatinib and/Or Nilotinib: 36-Month Update

Jorge E. Cortes, MD, H. Jean Khoury, MD, Hagop M. Kantarjian, MD, Jeff H. Lipton, MD, Dong-Wook Kim, MD, Maureen G. Conlan, MD, Eric Leip, PhD, Kathleen Turnbull, MD, Tim H. Brümmendorf, MD, Carlo Gambacorti-Passerini, MD

Blood (2013) 122 (21): 4025.

https://doi.org/10.1182/blood.V122.21.4025.4025

Published: 2013

Journal Articles

Weekly Combination Chemotherapy with Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) for Newly Diagnosed Patients with Advanced Cardiac Disease Due to Systemic AL Amyloidosis

Furha I. Cossor, MD, Adam Boruchov, MD, Michael Danso, MD, Michael Edward Lee, Ayan Patel, MD, Eric Winer, MD, Rodney Falk, MD, Raymond L. Comenzo, MD

Blood (2011) 118 (21): 5139.

https://doi.org/10.1182/blood.V118.21.5139.5139

Published: 2011

Journal Articles

Successful Control of Massive Gastrointestinal Bleeding Following Umbilical Cord Blood Transplantation (UCBT) by Use of Recombinant Activated Factor VII (rFVIIa) and Octreotide Infusion

Satya Prakash Yadav, MBBS, DCH, DNB, Anupam Sachdeva, Madasu Anjan, Nita Radhakrishnan, Sunil Bhat, Manas Kalra, Satyendra Katewa

Blood (2008) 112 (11): 4336.

https://doi.org/10.1182/blood.V112.11.4336.4336

Published: 2008

Journal Articles

Early vs Standard Intervention with an Extended Epoetin alfa (EPO) Dose Regimen of 120,000 Units (U) Every 3 Weeks (Q3W) in Chemotherapy (CT)-Induced Anemia: Results for Elderly vs. Younger Patients in a Randomized Clinical Trial.

Veena Charu, MD, Victor Moyo, MD, Donghan Luo, PhD, Francois E. Wilhelm, MD, PhD, MSc

Blood (2007) 110 (11): 3769.

https://doi.org/10.1182/blood.V110.11.3769.3769

Published: 2007

Journal Articles

Bleeding Diathesis in Patients (pts) with Chronic Myelogenous Leukemia Receiving Dasatinib Therapy.

Alfonso Quintás-Cardama, MD, Hagop Kantarjian, M.D., Farhad Ravandi, M.D., Jan Burger, M.D., Gautam Borthakur, M.D., Jorge Cortes, M.D.

Blood (2007) 110 (11): 2958.

https://doi.org/10.1182/blood.V110.11.2958.2958

Published: 2007

Journal Articles

Graft-Versus-Host Disease or Infection: Rapid Detection of HLA Mismatch-Reactive T Cells Ex Vivo Can Facilitate Diagnosis and Guide Therapy after Allogeneic Transplantation.

Eva Distler, Simone Thomas, Elke Schuerer, Cedrik Britten, Martin Schuler, Christoph Huber, Karin Kolbe, Thomas Woelfel, Ralf Meyer, Wolfgang Herr

Blood (2007) 110 (11): 4993.

https://doi.org/10.1182/blood.V110.11.4993.4993

Published: 2007

Journal Articles

Analysis of Causes and Outcome of Thrombocytopenia as a Presenting Symptom in a Single Institution.

Doris M. Kraemer, MD, Barbara Bauer, Joerg C. Rath, MD, Hermann Einsele, MD

Blood (2006) 108 (11): 3962.

https://doi.org/10.1182/blood.V108.11.3962.3962

Published: 2006

Journal Articles

Isolated, Idiopathic Splenic Vein Thrombosis, Presenting with Massive Lower GI Bleeding.

Aref Agheli, MD, Alka Arora, MD, Maged Khalil, MD, Seema Naik, MD, Theresa Dumlao, MD, William Steier, MD, Madhumati Kalavar, MD

Blood (2005) 106 (11): 4131.

https://doi.org/10.1182/blood.V106.11.4131.4131

Published: 2005

Journal Articles

Follow-Up of Clinical Manifestations and Platelet Function Test in Patients with Essential Thrombocythemia on Anagrelide Treatment.

Patricia S. Vassallu, MD, Nora P. Goette, Ana C. Glembotsky, Paula G. Heller, MD, Laura I. Kornblihtt, Ph.D, Paola R. Lev, Ph.D, Daniel C. Chazarreta, Juan P. Salim, Maria S. Laguna, Rosana F. Marta, Ph.D, Felisa C. Molinas, Ph.D.

Blood (2005) 106 (11): 4970.

https://doi.org/10.1182/blood.V106.11.4970.4970

Published: 2005

NARROW

Acquired Dysfibrinogenemia Krakow III after Everolimus Therapy

A Pilot Study of Exjade (Deferasirox) As Monotherapy in Higher Risk MDS or Acute Myeloid Leukemia

Von Willebrand Disease and Gastrointestinal Bleeding: A National Inpatient Sample (NIS) Study

Efficacy and Safety of Defibrotide in Pediatric Patients with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Stem Cell Transplantation (HSCT): Final Results from the Expanded-Access Program

Acquired Factor X Deficiency in Systemic Light Chain Amyloidosis: Factor X Recovery after Bleeding Complications, Splenectomy, Chemotherapy and Remission

Localization, Management, Resource Consumption and Outcome of Major Gastrointestinal Bleeding in Patients with Direct Oral Anticoagulants, Vka and Antiplatelet Therapy

A Phase Ib/II Study of Ibrutinib in Combination with Obinutuzumab-Gazyva As First-Line Treatment for Patients with Chronic Lymphocytic Leukemia > 65 Years Old or with Coexisting Conditions

Final Results of Phase 1 MMRC Trial of Selinexor, Carfilzomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma (RRMM)

Bleeding and Liver Transplant Outcomes in Hemophilia

FEIBA™ for Reversal of Direct Oral Anticoagulant Associated Major Bleeding

Bosutinib As Therapy For Chronic Phase Chronic Myeloid Leukemia Following Failure With Imatinib Plus Dasatinib and/Or Nilotinib: 36-Month Update

Weekly Combination Chemotherapy with Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) for Newly Diagnosed Patients with Advanced Cardiac Disease Due to Systemic AL Amyloidosis

Successful Control of Massive Gastrointestinal Bleeding Following Umbilical Cord Blood Transplantation (UCBT) by Use of Recombinant Activated Factor VII (rFVIIa) and Octreotide Infusion

Early vs Standard Intervention with an Extended Epoetin alfa (EPO) Dose Regimen of 120,000 Units (U) Every 3 Weeks (Q3W) in Chemotherapy (CT)-Induced Anemia: Results for Elderly vs. Younger Patients in a Randomized Clinical Trial.

Bleeding Diathesis in Patients (pts) with Chronic Myelogenous Leukemia Receiving Dasatinib Therapy.

Graft-Versus-Host Disease or Infection: Rapid Detection of HLA Mismatch-Reactive T Cells Ex Vivo Can Facilitate Diagnosis and Guide Therapy after Allogeneic Transplantation.

Analysis of Causes and Outcome of Thrombocytopenia as a Presenting Symptom in a Single Institution.

Isolated, Idiopathic Splenic Vein Thrombosis, Presenting with Massive Lower GI Bleeding.

Follow-Up of Clinical Manifestations and Platelet Function Test in Patients with Essential Thrombocythemia on Anagrelide Treatment.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only